Rigel Pharmaceuticals | Caixa E Equivalentes





Caixa e Equivalentes Alterar Data
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 36.04M 12.99M 2025-09
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Veracyte USD 315.57M 96.07M 2025-09


Rigel Pharmaceuticals Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.